Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer.

Gao M, Lin M, Moffitt RA, Salazar MA, Park J, Vacirca J, Huang C, Shroyer KR, Choi M, Georgakis GV, Sasson AR, Talamini MA, Kim J.

Br J Cancer. 2018 Oct 31. doi: 10.1038/s41416-018-0298-0. [Epub ahead of print]

PMID:
30377341
2.

A Comparative Analysis of Survival and Funding Discrepancies in Cancers with High Mortality.

Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Kumar S, Batra SK, Wang H, Ganti AK, Sasson AR, Are C.

Ann Surg. 2018 Sep 4. doi: 10.1097/SLA.0000000000003042. [Epub ahead of print]

PMID:
30188400
3.

Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.

Gao M, Lin M, Rao M, Thompson H, Hirai K, Choi M, Georgakis GV, Sasson AR, Bucobo JC, Tzimas D, D'Souza LS, Buscaglia JM, Davis J, Shroyer KR, Li J, Powers S, Kim J.

Ann Surg Oncol. 2018 Sep;25(9):2767-2775. doi: 10.1245/s10434-018-6662-8. Epub 2018 Jul 12.

PMID:
30003451
4.

Utility and limitations of exome sequencing as a genetic diagnostic tool for children with hearing loss.

Sheppard S, Biswas S, Li MH, Jayaraman V, Slack I, Romasko EJ, Sasson A, Brunton J, Rajagopalan R, Sarmady M, Abrudan JL, Jairam S, DeChene ET, Ying X, Choi J, Wilkens A, Raible SE, Scarano MI, Santani A, Pennington JW, Luo M, Conlin LK, Devkota B, Dulik MC, Spinner NB, Krantz ID.

Genet Med. 2018 Jun 15. doi: 10.1038/s41436-018-0004-x. [Epub ahead of print]

5.

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.

Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, Palmaira RLD, Javed AA, Huynh JC, Johnson M, Arora K, Robine N, Shah M, Sanghvi R, Goetz AB, Lowder CY, Martello L, Driehuis E, LeComte N, Askan G, Iacobuzio-Donahue CA, Clevers H, Wood LD, Hruban RH, Thompson E, Aguirre AJ, Wolpin BM, Sasson A, Kim J, Wu M, Bucobo JC, Allen P, Sejpal DV, Nealon W, Sullivan JD, Winter JM, Gimotty PA, Grem JL, DiMaio DJ, Buscaglia JM, Grandgenett PM, Brody JR, Hollingsworth MA, O'Kane GM, Notta F, Kim E, Crawford JM, Devoe C, Ocean A, Wolfgang CL, Yu KH, Li E, Vakoc CR, Hubert B, Fischer SE, Wilson JM, Moffitt R, Knox J, Krasnitz A, Gallinger S, Tuveson DA.

Cancer Discov. 2018 Sep;8(9):1112-1129. doi: 10.1158/2159-8290.CD-18-0349. Epub 2018 May 31.

PMID:
29853643
6.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

PMID:
29773717
7.

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.

Hellmann MD, Callahan MK, Awad MM, Calvo E, Ascierto PA, Atmaca A, Rizvi NA, Hirsch FR, Selvaggi G, Szustakowski JD, Sasson A, Golhar R, Vitazka P, Chang H, Geese WJ, Antonia SJ.

Cancer Cell. 2018 May 14;33(5):853-861.e4. doi: 10.1016/j.ccell.2018.04.001. Epub 2018 May 3.

PMID:
29731394
8.

Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years.

Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Ganti AK, Are C, Sasson AR, Kumar S, Batra SK.

Oncotarget. 2018 Apr 10;9(27):19396-19405. doi: 10.18632/oncotarget.25036. eCollection 2018 Apr 10.

9.

Blood vessel occlusion with erythrocyte aggregates causes burn injury progression-microvasculature dilation as a possible therapy.

Clark RAF, Fenner J, Sasson A, McClain SA, Singer AJ, Tonnesen MG.

Exp Dermatol. 2018 Jun;27(6):625-629. doi: 10.1111/exd.13518. Epub 2018 Apr 10.

PMID:
29478253
10.

Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment.

Tiriac H, Bucobo JC, Tzimas D, Grewel S, Lacomb JF, Rowehl LM, Nagula S, Wu M, Kim J, Sasson A, Vignesh S, Martello L, Munoz-Sagastibelza M, Somma J, Tuveson DA, Li E, Buscaglia JM.

Gastrointest Endosc. 2018 Jun;87(6):1474-1480. doi: 10.1016/j.gie.2017.12.032. Epub 2018 Jan 9.

PMID:
29325707
11.

Case report of intestinal non-rotation, heterotaxy, and polysplenia in a patient with pancreatic cancer.

Pagkratis S, Kryeziu S, Lin M, Hoque S, Bucobo JC, Buscaglia JM, Georgakis GV, Sasson AR, Kim J.

Medicine (Baltimore). 2017 Dec;96(49):e8599. doi: 10.1097/MD.0000000000008599.

12.

Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers.

Sanghvi RV, Buhay CJ, Powell BC, Tsai EA, Dorschner MO, Hong CS, Lebo MS, Sasson A, Hanna DS, McGee S, Bowling KM, Cooper GM, Gray DE, Lonigro RJ, Dunford A, Brennan CA, Cibulskis C, Walker K, Carneiro MO, Sailsbery J, Hindorff LA, Robinson DR, Santani A, Sarmady M, Rehm HL, Biesecker LG, Nickerson DA, Hutter CM, Garraway L, Muzny DM, Wagle N; NHGRI Clinical Sequencing Exploratory Research (CSER) Consortium.

Genet Med. 2018 Aug;20(8):855-866. doi: 10.1038/gim.2017.192. Epub 2017 Nov 16.

PMID:
29144510
13.

The role of feedback in implicit and explicit artificial grammar learning: a comparison between dyslexic and non-dyslexic adults.

Schiff R, Sasson A, Star G, Kahta S.

Ann Dyslexia. 2017 Oct;67(3):333-355. doi: 10.1007/s11881-017-0147-5. Epub 2017 Nov 13.

PMID:
29134484
14.

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK.

Cancer Cell. 2017 Sep 11;32(3):392. doi: 10.1016/j.ccell.2017.08.008. No abstract available.

15.

De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.

Tadros S, Shukla SK, King RJ, Gunda V, Vernucci E, Abrego J, Chaika NV, Yu F, Lazenby AJ, Berim L, Grem J, Sasson AR, Singh PK.

Cancer Res. 2017 Oct 15;77(20):5503-5517. doi: 10.1158/0008-5472.CAN-16-3062. Epub 2017 Aug 15.

16.

Eustachian tube dysfunction leading to middle-ear pathology in patients on chronic mechanical ventilation.

Ilan O, Marcus EL, Cohen Y, Farkash T, Levy R, Sasson A, Adelman C.

J Laryngol Otol. 2017 Sep;131(9):817-822. doi: 10.1017/S0022215117001554. Epub 2017 Jul 31.

PMID:
28758602
17.

Bioeconomy in Latin America.

Sasson A, Malpica C.

N Biotechnol. 2018 Jan 25;40(Pt A):40-45. doi: 10.1016/j.nbt.2017.07.007. Epub 2017 Jul 14. Review.

PMID:
28716653
18.

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK.

Cancer Cell. 2017 Jul 10;32(1):71-87.e7. doi: 10.1016/j.ccell.2017.06.004. Erratum in: Cancer Cell. 2017 Sep 11;32(3):392.

19.

Many Challenges of Peritoneal Carcinomatosis.

Sasson AR, Kim J.

J Oncol Pract. 2017 Jul;13(7):435-436. doi: 10.1200/JOP.2017.024588. No abstract available.

PMID:
28697322
20.

A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage.

Van Buren G 2nd, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG, Morgan KA, Hughes SJ, Karanicolas PJ, Allendorf JD, Vollmer CM Jr, Ly Q, Brown KM, Velanovich V, Winter JM, McElhany AL, Muscarella P 2nd, Schmidt CM, House MG, Dixon E, Dillhoff ME, Trevino JG, Hallet J, Coburn NSG, Nakeeb A, Behrns KE, Sasson AR, Ceppa EP, Abdel-Misih SRZ, Riall TS, Silberfein EJ, Ellison EC, Adams DB, Hsu C, Tran Cao HS, Mohammed S, Villafañe-Ferriol N, Barakat O, Massarweh NN, Chai C, Mendez-Reyes JE, Fang A, Jo E, Mo Q, Fisher WE.

Ann Surg. 2017 Sep;266(3):421-431. doi: 10.1097/SLA.0000000000002375.

PMID:
28692468
21.

Duodenal gangliocytic paraganglioma with lymph node metastases: A case report and comparative review of 31 cases.

Cathcart SJ, Sasson AR, Kozel JA, Oliveto JM, Ly QP.

World J Clin Cases. 2017 Jun 16;5(6):222-233. doi: 10.12998/wjcc.v5.i6.222.

22.

Effect of chunk strength on the performance of children with developmental dyslexia on artificial grammar learning task may be related to complexity.

Schiff R, Katan P, Sasson A, Kahta S.

Ann Dyslexia. 2017 Jul;67(2):180-199. doi: 10.1007/s11881-017-0141-y. Epub 2017 Apr 13.

PMID:
28409401
23.

Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial.

Verma V, Lazenby AJ, Zheng D, Bhirud AR, Ly QP, Are C, Sasson AR, Lin C.

Radiother Oncol. 2017 Mar;122(3):464-469. doi: 10.1016/j.radonc.2016.12.030. Epub 2017 Jan 12.

24.

Reduction of health care-associated infection indicators by copper oxide-impregnated textiles: Crossover, double-blind controlled study in chronic ventilator-dependent patients.

Marcus EL, Yosef H, Borkow G, Caine Y, Sasson A, Moses AE.

Am J Infect Control. 2017 Apr 1;45(4):401-403. doi: 10.1016/j.ajic.2016.11.022. Epub 2016 Dec 26.

25.

A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.

Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, Johansson SL, Jain M, Singh S, Guha S, Are C, Raimondo M, Hollingsworth MA, Brand RE, Batra SK.

Am J Gastroenterol. 2017 Jan;112(1):172-183. doi: 10.1038/ajg.2016.482. Epub 2016 Nov 15.

26.

Performance of children with developmental dyslexia on high and low topological entropy artificial grammar learning task.

Katan P, Kahta S, Sasson A, Schiff R.

Ann Dyslexia. 2017 Jul;67(2):163-179. doi: 10.1007/s11881-016-0135-1. Epub 2016 Oct 19.

PMID:
27761876
27.

Does dental health of 6-year-olds reflect the reform of the Israeli dental care system?

Natapov L, Sasson A, Zusman SP.

Isr J Health Policy Res. 2016 Oct 5;5:26. eCollection 2016.

28.

The next generation of target capture technologies - large DNA fragment enrichment and sequencing determines regional genomic variation of high complexity.

Dapprich J, Ferriola D, Mackiewicz K, Clark PM, Rappaport E, D'Arcy M, Sasson A, Gai X, Schug J, Kaestner KH, Monos D.

BMC Genomics. 2016 Jul 9;17:486. doi: 10.1186/s12864-016-2836-6.

29.

Islet Pericytes Are Required for β-Cell Maturity.

Sasson A, Rachi E, Sakhneny L, Baer D, Lisnyansky M, Epshtein A, Landsman L.

Diabetes. 2016 Oct;65(10):3008-14. doi: 10.2337/db16-0365. Epub 2016 Jul 7.

30.

Surgical Management of Liver Metastases From Colorectal Cancer.

Dhir M, Sasson AR.

J Oncol Pract. 2016 Jan;12(1):33-9. doi: 10.1200/JOP.2015.009407. Review.

PMID:
26759464
31.

Clinical presentation and outcome of nonfunctional pancreatic neuroendocrine tumors in a modern cohort.

Watley DC, Ly QP, Talmon G, Are C, Sasson AR.

Am J Surg. 2015 Dec;210(6):1192-5; discussion 1195-6. doi: 10.1016/j.amjsurg.2015.08.012.

PMID:
26674063
32.

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE.

PLoS One. 2015 Oct 2;10(10):e0139049. doi: 10.1371/journal.pone.0139049. eCollection 2015.

33.

Feasibility of a Dual Evaluation/Intervention Program for Morbidly Obese Adolescents.

Fennig S, Brunstein-Klomek A, Sasson A, Halifa Kurtzman I, Hadas A.

Isr J Psychiatry Relat Sci. 2015;52(2):107-12.

34.

Cauda Equina Syndrome in a 36 Week Gravida Patient.

Geftler A, Sasson A, Shelef I, Perry ZH, Atar D.

Isr Med Assoc J. 2015 Aug;17(8):522-3. No abstract available.

35.

Nodular Elastosis of the Pancreas.

Wedel W, Talmon G, Sasson A.

Case Rep Pathol. 2015;2015:521959. doi: 10.1155/2015/521959. Epub 2015 Aug 9.

36.

Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.

Kelsen JR, Dawany N, Moran CJ, Petersen BS, Sarmady M, Sasson A, Pauly-Hubbard H, Martinez A, Maurer K, Soong J, Rappaport E, Franke A, Keller A, Winter HS, Mamula P, Piccoli D, Artis D, Sonnenberg GF, Daly M, Sullivan KE, Baldassano RN, Devoto M.

Gastroenterology. 2015 Nov;149(6):1415-24. doi: 10.1053/j.gastro.2015.07.006. Epub 2015 Jul 17.

37.

Utility and limitations of exome sequencing as a genetic diagnostic tool for conditions associated with pediatric sudden cardiac arrest/sudden cardiac death.

Li MH, Abrudan JL, Dulik MC, Sasson A, Brunton J, Jayaraman V, Dugan N, Haley D, Rajagopalan R, Biswas S, Sarmady M, DeChene ET, Deardorff MA, Wilkens A, Noon SE, Scarano MI, Santani AB, White PS, Pennington J, Conlin LK, Spinner NB, Krantz ID, Vetter VL.

Hum Genomics. 2015 Jul 19;9:15. doi: 10.1186/s40246-015-0038-y.

38.

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.

Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, Batra SK, Singh PK.

Oncotarget. 2015 Aug 7;6(22):19118-31.

39.

Esophageal and esophagogastric junction cancers, version 1.2015.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Feb;13(2):194-227.

PMID:
25691612
40.

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.

PMID:
25099441
41.

Diagnosis and conservative management of late tracheotomy complications in chronic ventilator-dependent patients.

Ilan O, Gross M, Zaltzman Y, Sasson A, Marcus EL.

Head Neck. 2015 May;37(5):716-21. doi: 10.1002/hed.23665. Epub 2014 Jul 12.

PMID:
24596164
42.

Efficient digest of high-throughput sequencing data in a reproducible report.

Zhang Z, Leipzig J, Sasson A, Yu AM, Perin JC, Xie HM, Sarmady M, Warren PV, White PS.

BMC Bioinformatics. 2013;14 Suppl 11:S3. doi: 10.1186/1471-2105-14-S11-S3. Epub 2013 Sep 13.

43.

MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.

Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK.

Clin Cancer Res. 2014 Feb 1;20(3):688-700. doi: 10.1158/1078-0432.CCR-13-2174. Epub 2013 Nov 15.

44.

The mechanics of hyaluronic acid/adipic acid dihydrazide hydrogel: towards developing a vessel for delivery of preadipocytes to native tissues.

Shoham N, Sasson AL, Lin FH, Benayahu D, Haj-Ali R, Gefen A.

J Mech Behav Biomed Mater. 2013 Dec;28:320-31. doi: 10.1016/j.jmbbm.2013.08.009. Epub 2013 Aug 22.

PMID:
24021174
45.

Dominant form of congenital hyperinsulinism maps to HK1 region on 10q.

Pinney SE, Ganapathy K, Bradfield J, Stokes D, Sasson A, Mackiewicz K, Boodhansingh K, Hughes N, Becker S, Givler S, Macmullen C, Monos D, Ganguly A, Hakonarson H, Stanley CA.

Horm Res Paediatr. 2013;80(1):18-27. doi: 10.1159/000351943. Epub 2013 Jul 13.

46.

Mucins in pancreatic cancer and its microenvironment.

Kaur S, Kumar S, Momi N, Sasson AR, Batra SK.

Nat Rev Gastroenterol Hepatol. 2013 Oct;10(10):607-20. doi: 10.1038/nrgastro.2013.120. Epub 2013 Jul 16. Review.

47.

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 May 1;11(5):531-46.

PMID:
23667204
48.

Prognostic estimator of survival for patients with localized and extended pancreatic ductal adenocarcinoma.

Gleason MX, Mdzinarishvili T, Are C, Sasson A, Sherman A, Shats O, Sherman S.

Cancer Inform. 2013 Mar 18;12:103-14. doi: 10.4137/CIN.S11496. Print 2013.

49.

Combined hepatocellular cholangiocarcinoma: a case report and review of literature.

Singh S, Chakraborty S, Bonthu N, Radio S, Hussain SM, Sasson A.

Dig Dis Sci. 2013 Jul;58(7):2114-23. doi: 10.1007/s10620-013-2585-1. Epub 2013 Feb 9. Review. No abstract available.

PMID:
23397471
50.

Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.

Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK.

PLoS One. 2013;8(2):e55171. doi: 10.1371/journal.pone.0055171. Epub 2013 Feb 1.

Supplemental Content

Loading ...
Support Center